ACP Journal Club. Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
Ann Intern Med
.
2010 Mar 16;152(6):JC3-9.
doi: 10.7326/0003-4819-152-6-201003160-02009.
Author
Tejas V Patel
1
Affiliation
1
Brigham and Women's Hospital, Boston, Massachusetts, USA.
PMID:
20231563
DOI:
10.7326/0003-4819-152-6-201003160-02009
No abstract available
Publication types
Comment